Sign In

Richard Thompson

CEO at Findacure

Richard Thompson is a rare disease advocate and researcher with a background in evolutionary biology, research, and education, focused on evolutionary theory, mammalian evolution, and phylogenetics.

He has extensive experience in rare diseases, drug repurposing, and public health financing through his work at Findacure, where he developed a new financial model for funding drug repurposing.

His expertise spans the pharmaceutical industry, health economics, NHS, patient experiences in rare diseases, data mining, and business strategy.

Richard emphasizes collaborative working as vital for success in rare disease research and delivering treatments.

In addition to his professional work, he has a substantial teaching background, having taught undergraduate students and supervised at Cambridge University for over five years.

Richard Thompson holds a Master's Degree in Biosystematics with Distinction from Imperial College London, a Ph.D. in Evolutionary Biology from the University of Cambridge, and a Bachelor's Degree in Natural Sciences with First Class honors from the University of Cambridge.

He has held key roles such as CEO, former Head of Research, and former Scientific Officer at Findacure, demonstrating his leadership and expertise in the field.

Furthermore, his experience as a part-time Senior Technician at The University Museum of Zoology and an Editorial Assistant at Boardworks Ltd adds to his diverse skill set and knowledge base.

Highlights

Jun 26 · News-Medical.net
Teaching old drugs new tricks – drug repurposing for rare diseases - News-Medical.net
Feb 28 · Business Wire
Newron Supports Global Rare Disease Day® 2019 - Business Wire
Richard Thompson
Add to my network

Location

Cambridge, United Kingdom